Drug Database
Back to search

United States· US:71205-863_49b9759a-c1b9-4ebe-874b-81fb82a42755

Eplerenone

A eplerenone product containing eplerenone, registered in United States by Proficient Rx LP. The same ATC class is registered in 17 of our 19 countries.

ATC C03DA04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedEplerenoneATCC03DA04REGISTER NO.US:71205-863_49b9759a…PACKS LISTED16CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eplerenoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eplerenone is registered in 17 of 19 countries.

Countries holding a registration under ATC C03DA04 (eplerenone), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search eplerenone products by name

Eplerenone · ATC C03DA04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eplerenone costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.05 in France to $3.72 in Switzerland — a ×3.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Eplerenone · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.72
  • IT Italy$1.47
  • FR France$1.05
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EPLERENONE
Manufacturer
Proficient Rx LP
Country
United States (US)
ATC code
C03DA04
ATC class
Eplerenone
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 16

  • ndc11
    7120586300
    100 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-00)
  • ndc11
    7120586311
    1000 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-11)
  • ndc11
    7120586330
    30 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-30)
  • ndc11
    7120586355
    500 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-55)
  • ndc11
    7120586360
    60 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-60)
  • ndc11
    7120586372
    120 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-72)
  • ndc11
    7120586378
    180 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-78)
  • ndc11
    7120586390
    90 TABLET, COATED in 1 BOTTLE, PLASTIC (71205-863-90)
  • ndc11
    71205-863-00
  • ndc11
    71205-863-11
  • ndc11
    71205-863-30
  • ndc11
    71205-863-55
  • ndc11
    71205-863-60
  • ndc11
    71205-863-72
  • ndc11
    71205-863-78
  • ndc11
    71205-863-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

230 interactions on record for eplerenone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check eplerenone against other medicinesHow interaction checks work

Eplerenone · interactions on record

230 records

  • 32 severe
  • 97 moderate
  • 3 minor
  • 24 info

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • AprepitantA04AD12severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eplerenone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eplerenone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Eplerenon +pharma, Eplerenon Actavis
  • Belgium · Eplerenone Ab, Inspra
  • Bulgaria · Eспиро, Аплериа
  • Cyprus · Apleria, Eplerenone Accord
  • Czechia · Apleria, Eplerenon Medreg
  • Germany · Epleraxiro, Eplerenon 1 A Pharma
  • Denmark · Eplerathen, Eplerenon Accord
  • Estonia · Apleria
  • Spain · Elecor, Eplerenona Alter
  • Finland · Inspra
  • France · Eplerathen, Eplerenone Accord
  • United Kingdom (Northern Ireland) · Eplerenone, Eplerenone Accord Healthcare
  • Greece · Apleria, Eleveon
  • Croatia · Apleria, Diuron
  • Hungary · Diupot, Eplerenon Krka
  • Ireland · Eplerenone Accord Healthcare, Eplerenone Krka
  • Iceland · Eplerenon Bluefish, Eplerenon Krka
  • Italy · Eplerenone Accord, Eplerenone Doc Generici
  • Lithuania · Apleria
  • Luxembourg · Inspra
  • Latvia · Enplerasa, Plecard
  • Netherlands · Eplerenon Accord, Eplerenon Amarox
  • Norway · Eplerenon Accord, Eplerenon Krka
  • Poland · Eleveon, Enplerasa
  • Portugal · Eplerenona Biofarmoz, Eplerenona Blovasc
  • Romania · Apleria, Eplerenonă Arena
  • Sweden · Eplerenon Accord, Eplerenon Bluefish
  • Slovenia · Elreptic, Enplerasa
  • Slovakia · Aldepla, Apleria

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/39f74b37-babe-456f-b0a8-b425a8e0a746
GET /v1/drugs/39f74b37-babe-456f-b0a8-b425a8e0a746?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "25",
  "substance": "EPLERENONE",
  "productndc": "71205-863",
  "dosage_form": "TABLET, COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA207842",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about eplerenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console